NATHAN FOWLER to Phosphatidylinositol 3-Kinases
This is a "connection" page, showing publications NATHAN FOWLER has written about Phosphatidylinositol 3-Kinases.
Connection Strength
0.232
-
Kinase inhibitors in CLL: drawing the roadmap. Blood. 2021 05 20; 137(20):2717-2719.
Score: 0.118
-
Idelalisib in the management of lymphoma. Blood. 2016 07 21; 128(3):331-6.
Score: 0.084
-
Preclinical and phase I studies of KA2237, a selective and potent inhibitor of PI3K ?/d in relapsed refractory B cell lymphoma. Leuk Lymphoma. 2021 12; 62(14):3452-3462.
Score: 0.030